OpenEvidence has signed content agreements with JAMA and The New England Journal of Medicine.

OpenEvidence was founded in 2022 by Daniel Nadler, a Harvard Ph.D. and former founder of Kensho, a financial analytics firm acquired by S&P Global in 2018. [2][3] Nadler launched the …

Jun 5, 2025 · Open Evidence is an experimental technology that CANNOT fully substitute your clinical judgement and assessment of current guidelines/literature when making clinical decisions.

Oct 20, 2025 · OpenEvidence, which Forbes profiled in July, has been signing up users fast. Its ultimate goal: To not just help doctors find existing medical research, but to create medical …

Oct 20, 2025 · OpenEvidence, a medicine-focused chatbot, now supports 15 million clinical consultations a month, according to the company. OpenEvidence

‎Clinical Decision Support for Healthcare Professionals (NPI Required). OpenEvidence is the world’s leading medical information platform for health care professionals, providing accurate …

We are dedicated to providing high-quality, evidence-based information at your fingertips. In this update, OpenEvidence maintains its emphasis on grounding information in verifiable, …

OpenEvidence is an AI-powered application that allows physicians to ask natural language questions and get immediate answers grounded in peer-reviewed medical evidence from …

Oct 21, 2025 · As AI competition heats up, OpenEvidence’s rise shows investor confidence shifting toward purpose-built models designed for high-stakes industries like medicine.

Sep 7, 2025 · What is Open Evidence and what are its strengths? Open Evidence is an AI-based paper review support platform designed for healthcare professionals. It cites and generates …